Model N, a leading end-to-end commercialization, revenue optimization, and compliance platform for life sciences companies, announced it has acquired Kalderos, a technology company that provides a gross-to-net (GTN) intelligence platform with rich capabilities for driving visibility into 340B drug discount programs. The acquisition will expand Model N’s capabilities as a leading revenue management platform for life sciences manufacturers and extend its 340B offerings to better serve customers. 340B, a federal program that requires drug manufacturers to sell outpatient drugs at discounted prices to eligible safety-net hospitals and clinics, is a core and growing component of the overall GTN value chain.
Read the full article: Model N Acquires Kalderos to Expand Its 340B Capabilities and Gross-to-Net Revenue Management //
Source: https://www.modeln.com/company/news/press-center/model-n-acquires-kalderos-to-expand-its-340b-capabilities-and-gross-to-net-revenue-management/